Drs. Sophia O’Brien Austin Pantel, explore the role of 18F-Fluoroestradiol (FES) PET-CT in the diagnosis and management of ER-positive breast cancer. They review key findings from their RadioGraphics article, discuss updates to national guidelines, and highlight how FES imaging improves patient care by assessing estrogen receptor expression across all sites of disease.
